Volume dodolan perusahaan septerna.com (SEPN)
Septerna Inc is investing in breakthrough Native GPCR technology to develop small molecules targeting immune pathologies. On GURU.Markets, the company's sales structure and volume reflect a trend where the current parameter equals 0.10. Risks are minimized through the diversification of cell receptor therapies. The startup's environmental footprint is minimal, limited only to compliance with laboratory waste disposal regulations.
Rincian analitis perusahaan Septerna Inc
- rega lan prakiraan konsensus rega:
- rincian kapitalisasi pasar:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Utang marang Modal Septerna Inc|SEPN - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas Septerna, Inc.|SEPN - Gunggung utang perusahaan|Utang marang modal buku Septerna Inc|SEPN - Utang jangka dawa perusahaan|Utang jangka cendhak Septerna|Rasio jangkoan perantara septerna.com
- data bathi bisnis lan rasio investasi:
SEPN - Bathi resik perusahaan|Prakiraan bathi resik Septerna Inc|SEPN - Pangali P/E|Pangali Forward P/E septerna.com|SEPN - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Septerna Inc|SEPN - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Septerna|SEPN - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan septerna.com|SEPN - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Septerna Inc
- indikator volume dodolan lan pendapatan:
Analisis umum perusahaan:Septerna Pharma, SEPN
Septerna Inc is scaling its immune pharmaceuticals through synergy with research centers and the Native GPCR platform. By analyzing the company's commercial revenue trend, an investor assesses the monetization efficiency of these strategic alliances. This metric captures the speed at which market demand for targeted drugs transforms into operating income. Comparing daily price action with previous periods prevents purchasing the asset at an emotional peak, which confirms the fundamental stability of the business model.
Pesaing wigati
Pendapatan lan volume dodolan argenx BVBA|Pendapatan perusahaan BioNTech SE (BNTX)|Abivax SA - Volume dodolan perusahaan|Pendapatan lan volume dodolan ADMA (ADMA Biologics, Inc.)|Protagonist Therapeutics, Inc. (PTGX) - Total pendapatan perusahaan|IMVT - Pendapatan perusahaan|Pendapatan reged perusahaan Kiniksa Corp KNSA|GRFS: Pendapatan lan volume dodolan|Total pendapatan perusahaan adaptivebiotech.com (ADPT)|Pendapatan perusahaan Celldex Therapeutics, Inc.|Aurinia Pharmaceuticals Inc - Pendapatan tahunan perusahaan|Dodolan perusahaan BCRX (BioCryst Pharmaceuticals Inc)|Total dodolan perusahaan VERA|Pendapatan lan volume dodolan DNTH (Dianthus Therapeutics)|pharvaris.com (PHVS) - Total pendapatan perusahaan|ABCL - Pendapatan perusahaan|Pendapatan dodolan perusahaan TRML (Tourmaline Bio Inc)|Intrexon (PGEN) - Pendapatan perusahaan|Volume dodolan perusahaan PHAR|NKTR (Nektar Therapeutics) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan upstreambio.com|Dodolan perusahaan ZBIO (Zenas Biopharma)|IMNM (Immunome Inc) - Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan GOSS (Gossamer Corp)|Pendapatan reged perusahaan KalVista Corp (KALV)|PVLA - Pendapatan perusahaan|SVRA (savarapharma.com) - Volume dodolan perusahaan|RIGL: Pendapatan lan volume dodolan|Dodolan perusahaan AnaptysBio Inc|Pendapatan perusahaan Astria Pharma|enGene Corp (ENGN) - Pendapatan reged perusahaan|Pendapatan lan volume dodolan RAPT|JBIO - Total pendapatan perusahaan|Pendapatan perusahaan Aclaris Therapeutics, Inc. ACRS|KYTX (Kyverna Therapeutics Inc.) - Pendapatan tahunan perusahaan|TLSA - Pendapatan perusahaan|CABA (Cabaletta Bio Inc) - Volume dodolan perusahaan|Ventyx Biosciences (VTYX) - Pendapatan perusahaan|Pendapatan tahunan perusahaan THTX (theratech.com)|AVTX (Avalo Therapeutics) - Pendapatan lan volume dodolan|ELDN: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan AGEN|Pendapatan lan volume dodolan Climb Bio, Inc (CLYM)|Pendapatan perusahaan Zura Bio Limited ZURA|Pendapatan dodolan perusahaan ATYR|ADAG - Pendapatan perusahaan|ImageneBio Inc (IMA) - Dodolan perusahaan|STTK: Pendapatan lan volume dodolan|Equillium (EQ) - Pendapatan lan volume dodolan|Dodolan perusahaan CNTB|IMUX: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan ATRA|Pendapatan reged perusahaan inflarx.de|Pendapatan perusahaan X4 Pharma XFOR|ACET - Dodolan perusahaan|CELU - Pendapatan perusahaan|inmunebio.com (INMB) - Dodolan perusahaan|BRNS (Barinthus Biotherapeutics plc) - Dodolan perusahaan|Kezar Life Sciences Inc. (KZR) - Pendapatan lan volume dodolan|Pendapatan perusahaan SAB Biotherapeutics, Inc|Volume dodolan perusahaan AKTX (Akari Therapeutics, Plc)|Pendapatan lan volume dodolan ENLV|QTTB - Total pendapatan perusahaan|Pendapatan perusahaan GeoVax GOVX|Pendapatan reged perusahaan Edesa Biotech Inc (EDSA)|iBio Corp - Pendapatan lan volume dodolan|Total pendapatan perusahaan Carisma Therapeutics|XTL Biopharmaceuticals (XTLB) - Pendapatan perusahaan|Pendapatan tahunan perusahaan BOLT (Bolt Biotherapeutics, Inc.)|Dodolan perusahaan HCWB|APVO (Aptevo) - Total dodolan perusahaan|Pendapatan lan volume dodolan AIM|ADTX - Total pendapatan perusahaan|Pendapatan perusahaan GRI Bio, Inc. GRI|Pendapatan dodolan perusahaan XRTX|HIND - Pendapatan perusahaan|REVB (Revelation Biosciences Inc) - Volume dodolan perusahaan|INDP: Pendapatan lan volume dodolan|BiondVax Pharmaceuticals (SCNI) - Pendapatan lan volume dodolan|Dodolan perusahaan CALI|AFMD: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan ALLK|Pendapatan reged perusahaan hookipapharma.com|Pendapatan perusahaan IGM Biosciences IGMS|ITOS: Volume dodolan perusahaan|Ocean Biomedical, Inc. - Pendapatan lan volume dodolan|tcbiopharm.com (TCBP) - Dodolan perusahaan|Third Harmonic Bio, Inc. (THRD) - Pendapatan perusahaan
